Is NextEra Energy (NEE) One of the Best Clean Energy Stocks to Buy Right Now?
NextEra Energy, Inc. (NYSE:NEE) is included among the 10 Best Clean Energy Stocks to Buy Right Now.
With a market cap of over $194 billion as of the writing of this article,
» Read more about: Is NextEra Energy (NEE) One of the Best Clean Energy Stocks to Buy Right Now? »
Read MoreIs Phillips 66 (PSX) Among the Energy Stocks that Crushed Earnings Estimates in the First Quarter?
Phillips 66 (NYSE:PSX) is included among the 10 Energy Stocks that Crushed Earnings Estimates in the First Quarter.
Phillips 66 (NYSE:PSX) is a diversified and integrated downstream energy provider that manufactures,
Read MoreDebt Mutual Funds That Suit First-Time Lumpsum Investors
The Question Every First-Time Investor Eventually Asks
At some point, most people sitting on a decent sum of saved money ask the same question — what do I do with this without taking unnecessary risk? Fixed deposits are the default answer, but they have been quietly losing the battle against inflation for years.
» Read more about: Debt Mutual Funds That Suit First-Time Lumpsum Investors »
Read MoreWarren Buffett's Successor, Greg Abel, Just Sold 16 Stocks, but Piled Into an AI Titan That's Now a Top-5 Position for Berkshire Hathaway
Big changes are afoot at Berkshire Hathaway (NYSE: BRKA)(NYSE: BRKB). With Warren Buffett retiring as CEO on Dec. 31, 2025, the baton was handed to his longtime understudy, Greg Abel. Though the Oracle of Omaha remains chair of the board, Abel has the final say on Berkshire’s day-to-day operations and its massive investment portfolio.
Stock market today: Dow, S&P 500, Nasdaq futures rise in countdown to Nvidia earnings
The Burst
1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services,
» Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read MoreThe Ivy
The Danger Is Still High, Here’s Why
After a face-ripping rally Wednesday, markets took a breather yesterday. Futures were pointing lower, which, frankly, wasn’t all that surprising given how sharply things ripped higher.
But while some have pointed to a bottom, the reality is the danger is still high. Look no further than how the rally failed at the downtrending resistance line.
» Read more about: The Danger Is Still High, Here’s Why »
Read MoreThe Spotlight
Spotlight: 1 High-paying Dividend Stock Is Way Undervalued
Wall Street analysts seem pretty gung-ho about Realty Income, pegging an average price target at $68 per share, a significant pop from where the stock sits now. That’s in addition to a dividend yield north of 6%.
Is Wall Street right or is the recent selloff indicative of what’s to come for Realty Income?
» Read more about: Spotlight: 1 High-paying Dividend Stock Is Way Undervalued »